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ABSTRACT 
 
There is conflicting evidence on the 
association between PCOS and early 
and late obstetric complications. It is 
unclear if the reported risks are 
independent of BMI, preexisting 
hypertension and diabetes. We 
performed a retrospective chart review 
to examine the risk of early and late 
obstetrical complications after IVF in 
women with PCOS (n=130) compared to 
controls (n=130). The miscarriage rate 
was 17.7% in PCOS women and 15.4% 
in controls. PCOS was not associated 
with miscarriage independent of age 
and BMI. The prevalence of gestational 
DM (GDM) was similar in both groups 
(12% PCOS versus 11% controls). BMI 
was independently associated with 
GDM (p=0.01). Risk of both pre-
eclampsia and PIH was 10% in PCOS 
and 5% in controls, but not statistically 
significant. Preexisting HTN showed a 
significant association with 
preeclampsia (p<0.01). There was no 
significant difference in preterm delivery, 
twin gestation, intrauterine fetal death 
and intrauterine growth restriction in the 
2 groups. Our study did not detect an 
increased risk of miscarriage in women 
with PCOS undergoing IVF. Obesity 
was a significant contributor to late 
obstetric complications, namely GDM. 
These findings warrant counseling of 
women with PCOS especially prior to 
IVF on the potential benefits of weight 
loss prior to pregnancy. 
 
1Department of Obstetrics and Gynecology, 
University of Iowa, Iowa City, USA 52242 and 2 
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Summary for Lay Readers 
 
There is conflicting evidence on the 
association between polycystic ovary 
syndrome (PCOS) and early and late 
pregnancy complications. It is unclear if 
the reported risks are independent of 
maternal weight and medical conditions 
such as preexisting hypertension and 
diabetes. We performed a study to 
examine the risk of early and late 
pregnancy complications after in vitro 
fertilization in a large group of women 
with PCOS (n=130) compared to 
controls (n=130). The miscarriage rate 
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was similar in PCOS women and 
controls. PCOS was not associated with 
miscarriage independent of age and 
BMI. The prevalence of gestational DM 
(GDM) was also similar in both groups 
(12% PCOS versus 11% controls). 
PCOS was not associated with GDM, 
however, maternal weight was 
significantly associated with GDM. Risk 
of both pre-eclampsia and pregnancy 
induced hypertension was 10% in 
PCOS and 5% in controls, but not 
statistically significant. Women with 
preexisting hypertension had a higher 
risk of developing preeclampsia. There 
was no significant difference in preterm 
delivery, Cesarean section, twin 
gestation, intrauterine fetal death and 
intrauterine growth restriction in the 2 
groups. Our study shows that obesity 
was a significant contributor to 
pregnancy complications such as 
gestational diabetes. These findings 
may warrant aggressive counseling of 
women with PCOS on the potential 
benefits of weight loss prior to 
pregnancy. 
 
 
INTRODUCTION 
 
Polycystic ovary syndrome (PCOS) is 
one of the most common endocrine 
disorders affecting women of child-
bearing age, with an estimated 
prevalence of about 5-10% as reported 
in population-based studies1. PCOS is a 
chronic disorder associated with both 
reproductive complications and early 
onset metabolic morbidities2. Women 
with PCOS can be very successful in 
achieving a pregnancy after treatment 
with ovulation induction drugs3.  The 
increased prevalence of metabolic 
abnormalities associated with PCOS 
however, may have lifelong health 
implications2. Several studies in diverse 
populations of PCOS women have 
demonstrated an increased risk of 
hyperinsulinemia2, insulin resistance, 
dyslipidemia4, glucose intolerance5, 
hypertension2 and metabolic syndrome6. 
Over 50% of women with PCOS are 
either overweight or obese further 
modifying this metabolic phenotype7. 
We have recently reported that obesity 
itself is associated with adverse 
reproductive and obstetric outcomes8. In 
addition, pregnancy is characterized as 
a state of insulin resistance9. The 
metabolic risks of PCOS may therefore 
adversely affect both maternal and fetal 
status, potentially leading to an 
increased manifestation of 
complications such as gestational 
diabetes mellitus (GDM), pregnancy 
induced hypertension (PIH) and 
preeclampsia.       
  
There is conflicting evidence on the 
association between PCOS and early 
and late obstetric complications. A few 
studies have reported an increased risk 
of obstetric and neonatal complications 
in women with PCOS10. Limitations of 
some of these studies include small 
study sizes, differing diagnostic criteria 
for PCOS and heterogeneity in 
controlling for variables such as 
maternal BMI, parity, preexisting 
diabetes and hypertension. It is 
therefore not clear if PCOS per se 
increases the risk of antepartum 
complications or if the presence of 
preexisting metabolic abnormalities 
increases the overall obstetric risks in 
PCOS.  
 
Our primary aim was to determine the 
risk of early obstetric complications such 
as spontaneous miscarriage and late 
complications such as GDM, PIH, 
preeclampsia and preterm delivery 
(PTD) in a large group of women with 
PCOS compared to controls. Our 
secondary aim was to determine the 
effects of PCOS on neonatal outcomes.  
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METHODS 
 
We reviewed pregnancy outcomes in 
women with PCOS (n=130) and controls 
(women with tubal factor infertility, 
n=130) who had in vitro fertilization (IVF) 
between 1995 and 2007 at the 
University of Iowa Hospitals & Clinics. 
Subjects who had a diagnosis of PCOS 
based on the 2003 Rotterdam criteria 
(presence of at least two of the following 
three criteria: oligomenorrhea (<9 
cycles/year), clinical and/or biochemical 
signs of hyperandrogenism, and 
polycystic ovaries on ultrasound) were 
included in the study11.  Subjects who 
had a two step approach to screening 
for gestational diabetes were included in 
the study. An initial screen was 
performed by measuring the 1 hour 
glucose level after a 50g oral glucose 
load. The 3 hour oral glucose tolerance 
test (GTT) was performed if the 
screening level was >140mg/dl. 
Gestational diabetes mellitus (GDM) 
was defined as two or more abnormal 
blood glucose levels on a 3 hour GTT 
(fasting ≥ 95mg/dl, 1hr level≥ 180mg/dl, 
2hr level ≥ 155mg/dl, 3hr level ≥ 
140mg/dl)12. Pregnancy induced 
hypertension (PIH) was defined as 
blood pressure ≥ 140/90 mmHg after 20 
weeks gestation without proteinuria and 
with normal blood pressure prior to 
pregnancy.  Preeclampsia was defined 
as blood pressure ≥ 140/90 mmHg after 
20 weeks gestation and proteinuria 
(>300mg) determined on a 24 hour urine 
collection.  This information was 
abstracted from the medical records and 
IVF database. Subjects with incomplete 
obstetric records were excluded from 
the study. Control subjects with only 
tubal factor infertility were selected 
consecutively from the IVF database to 
match the similar time period, age (+/- 5 
years) and BMI (+/-2) of the PCOS 
subjects.  
 
Other variables that were compared 
included gravidity, parity, current 
smoking, pre-existing diabetes, 
hypertension and use of medications to 
treat these latter conditions.  Prior to the 
current pregnancy impaired fasting 
glucose (IFG) was defined as having a 
fasting blood glucose level of 100-
125mg/dL and diabetes was defined as 
glucose ≥126mg/dl. For subjects who 
had a 2h GTT, impaired glucose 
tolerance (IGT) was defined as 2 hour 
glucose level of 140-199mg/dl and 
diabetes was defined as glucose 
≥200mg/dl. Antepartum outcomes 
analyzed included miscarriage rate (loss 
before 20 weeks gestation), GDM, PIH, 
preeclampsia, preterm delivery (PTD 
<37 weeks), intrauterine growth 
restriction (IUGR,) and intrauterine fetal 
demise (IUFD).  Intrapartum and 
neonatal outcomes were also compared 
between control and study groups. 
 
The Wilcoxon rank sum test was used to 
evaluate differences between 
continuous variables and the Fisher 
exact test and Chi-squared test was 
performed for categorical variables to 
compare demographic data between the 
PCOS group and controls.  Multiple-
logistic regression analysis was 
performed to control for variables that 
significantly differed in the two groups.  
Statistical significance was defined as p 
< 0.05.  We had 80% power to detect a 
2 fold difference in miscarriage rates 
between women with PCOS and 
controls at the 0.05 significance level. 
This study was approved by the 
University of Iowa Institutional Review 
Board.  
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RESULTS 
 
Demographics  
 
Women with PCOS were slightly 
younger (mean age 31.1±4.3years than 
controls 33±3.7years), and had a higher 
prepregnancy BMI compared to the 
controls (mean BMI 31±8 vs. controls 
28.9±5.5, p<0.05, Table 1). The PCOS 
subjects had fewer prior pregnancies 
and miscarriages than the controls. 
However, women with PCOS had a 
higher miscarriage rate per pregnancy 
50% (42/85) compared to that in 
controls 24% (81/341, p<0.01).  Similar 
proportions of women with PCOS and 
controls had preexisting hypertension 
(10% vs 6%) and hypothyroidism (10% 
vs 7%). In the PCOS group 29% had 
IFG/IGT and 5% had type 2 diabetes. A 
higher proportion of women with PCOS 
had taken insulin sensitizing agents, 
namely metformin, prior to the current 
pregnancy compared to controls (23.9% 
vs 0.8%). All 5 subjects with DM, 9/30 
subjects with IFG/IGT and 14 other 
subjects were prescribed metformin. 
The majority of women with PCOS 
(54%) met all three diagnostic criteria 
namely oligomenorrhea, 
hyperandrogenism and polycystic 
ovaries.  
 
Table 1. Demographic characteristics of women with PCOS and Controls 
Variable PCOS (n=130) Controls (n=130) 
Mean age in years (SD) 31.1 (4.3) 33.0 (3.7)** 
Mean prepregnancy BMI,  (SD) 31 (8) 28.9 (5.5)* 
Duration of infertility in months (SD) 45.1 (2.7) 46.9(3.9) 
Nulligravid 78(60%) 20 (15%) ** 
Previous miscarriage 
        0 
        1 
        2 
 
98(75%) 
25(19%) 
7 (5%) 
 
81 (62%)* 
30(23%) 
19 (15%) 
Race 
   Caucasian 
   Hispanic 
   African  American 
   Asian 
   Other  
   Unknown 
 
87% 
3% 
2% 
2% 
0% 
6% 
 
88% 
1% 
3% 
1% 
1% 
6% 
Smoking: Current 4 (3%) 
2 missing 
12 (10%)* 
15 missing 
*p<0.05, **p<0.01 
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Early Obstetric Complications  
 
Miscarriage rate: The miscarriage rate 
(all spontaneous losses <20 weeks) in 
women with PCOS was 17.7% (23/130) 
compared to 15.4% (20/130) in controls 
(Table 2). A higher number of PCOS 
subjects had second trimester 
miscarriages compared to controls but 
this was not statistically significant. In 
addition, seven twin pregnancies 
spontaneously reduced to singletons in 
the PCOS group compared to 14 twin 
pregnancies in the control group. Two 
PCOS subjects with diabetes (2/5) and 
5 PCOS subjects with IGT/IFG (5/30) 
had a miscarriage. PCOS was not found 
to be significantly associated with 
miscarriage (p=0.495) after adjusting for 
age, BMI, and previous miscarriage in a 
logistic regression model. Age appeared 
to have a weak association with 
miscarriage rate (OR1.48, 95% CI: 0.96, 
2.26, p<0.07). 
 
Late Obstetric complications 
 
Gestational Diabetes: The percentage 
of women with ongoing pregnancy 
beyond 20 weeks who developed GDM 
was not significantly different in the two 
groups, PCOS 12.2% (13/102) and 
controls 10.9% (12/109) (p=0.78, Table 
2). The subjects with preexisting 
diabetes (PCOS 5, controls 1) were not 
included in this analysis. The logistic 
regression model for GDM with PCOS, 
age, and BMI as independent variables 
showed that BMI was significantly 
associated with GDM after adjusting for 
age and diagnosis of PCOS (OR 1.44, 
95% CI: 1.09-1.92, p<0.01). PCOS was 
not found to be significantly associated 
with GDM (p=0.678) after adjusting for 
age and BMI. PCOS women with 
singletons (n=73) had a 15.1% 
prevalence of GDM compared to 13.2% 
in controls with singletons (n=76, Table 
3). The rate of multiple pregnancy was 
similar in both groups, 32% (34) in 
PCOS and 31% (29) in controls (Table 
3). Of the 25 PCOS women with 
IFG/IGT with ongoing pregnancies, 5 
developed GDM (20%) and three of the 
latter women had been treated with 
metformin prior to pregnancy.  
 
Pregnancy induced 
hypertension/preeclampsia: The 
prevalence of PIH was two times higher 
in women with PCOS than that of 
controls (10.28% vs. 5.45%, p=0.186, 
Table II) as was the prevalence of 
preeclampsia (PCOS 10.28% compared 
to controls 5.45%, Table 2).  The 
association between PCOS and PIH 
after adjusting for the effect of smoking 
was not significant (p=0.073). Pre-
existing hypertension had a significant 
association with development of 
preeclampsia in both groups (OR 5.02, 
95% CI: 1.39-18.16, p<0.01). Also, 
nulligravidity had a strong association 
with the development of preeclampsia in 
both groups (OR 7.30, 955 CI: 1.97, 
27.04, p<0.003). PCOS was not found 
to be significantly associated with 
preeclampsia after adjusting for any of 
the above covariates.  
 
Preterm Delivery: The overall risk of 
PTD was 26% in women with PCOS 
compared to 26% in controls (p=0.9, 
Table 2).  PCOS was not found to be 
significantly associated with PTD after 
adjusting for multiple pregnancy, age, 
BMI, and parity (p=0.6). Twin gestation 
had a significantly higher risk of PTD in 
the PCOS and control groups (OR 
13.31, 95% CI: 5.98-29.6, p<0.001, 
Table 3). In addition, BMI also had a 
significant association with PTD (OR 
1.34, 955 CI: 1.03-1.76, p<0.03).  
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Table 2. Obstetric complications in women with PCOS and Controls 
Variable PCOS Controls 
Miscarriage 
<12 weeks 
12-20weeks 
23(17.7%) 
17 
6 
20(15.4%) 
19 
1 
Twin gestation 34 (32%) 29 (31%) 
Gestational Diabetes (GDM) 13 (12.2%) 12 (10.9%) 
Pregnancy induced  
hypertension(PIH) 11 (10.3%) 6 (5.5%) 
Preeclampsia 11 (10.3%) 6 (5.5%) 
Preterm delivery 
(PTD) 26 (24%) 26 (24%) 
Intrauterine fetal death(IUFD) 0 1(0.9%) 
Intrauterine growth restriction(IUGR) 2 (2%) 4 (4%) 
 
Table 3. Obstetric Complications: Singleton compared to Twin gestation in 
women with PCOS and controls   
 
 PCOS Controls 
Variable Singleton  (n=73) 
Twin 
(n=34) 
Singleton  
(n=76) 
Twin  
(n=29) 
Gestational Diabetes (GDM) 11 (15.1%) 2 (5.9%) 10 (13.2%) 2 (5.9%) 
Pregnancy induced hypertension 
(PIH) 7 (9.6%) 4 (11.8%) 6 (7.9%) 0 (0%) 
Preeclampsia 7 (9.6%) 4 (11.8%) 3 (3.9%) 3 (8.8%) 
Preterm delivery (PTL) 6 (8.2%) 20 (58.8%) 8 (10.5%) 18(62%) 
IUGR 1 (1.4%) 1 (2.9%) 3 (3.9%) 1 (2.9%) 
 
Neonatal & Intrapartum Outcomes: 
Women with PCOS had a total of 107 
deliveries and controls had 110 
deliveries.  There was no significant 
difference in delivery mode in either 
group, with approximately 44% women 
delivering by cesarean section (Table 
4). The mean birth weights of both 
singletons and twin gestation did not 
differ between groups and the incidence 
of macrosomia (birth weight>4000g) 
was not statistically different in infants of 
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controls compared to infants of women 
with PCOS. The risk of IUGR was 
higher in the control group compared to 
the PCOS group, however the numbers 
in each group were small and not 
significantly different (p=0.68). 
 
Table 4. Neonatal & Intrapartum Outcomes in women with PCOS compared to 
Controls 
 
Variable PCOS (n=107) Controls (n=110) 
Delivery Mode 
    C-Section 
 
48 (45%) 
 
47 (43%) 
Birth Weight, mean(SD) 
       Singleton (g) 
       Twins (g) 
 
3383(681) 
2376(796) 
 
3384 (771) 
2474 (639) 
Macrosomia (>4,000 g) 10 (6.9%) 12 (8.3%) 
Infant Gender 
       Male 
 
80 (56%) 
 
74 (51%) 
 
DISCUSSION 
 
Women with PCOS need to be 
accurately counseled regarding their 
obstetric risks especially if some of 
these risks can be modified by 
interventions such as weight loss. We 
included a large group of well defined 
subjects with PCOS undergoing IVF and 
attempted to match them based on key 
factors such as age and BMI. After 
using logistic regression for confounding 
factors our study did not show an 
increased risk of miscarriage in women 
with PCOS independent of BMI. This 
supports previous data from a meta-
analysis of nine studies that reported no 
significant difference in miscarriage 
rates between PCOS and non-PCOS 
patients after IVF (random effects OR 
1.0; 95% CI 0.5 to 1.8)13. The results of 
the meta-analysis were however limited 
in that not all studies were matched for 
age or BMI and most included multiple 
cycles from one subject. Regardless of 
the method of conception women with a 
BMI ≥ 25 have been shown to have a 
significantly higher odds of miscarriage 
(OR 1.67; 95% CI, 1.25-2.25)14. In IVF- 
conceived pregnancies, women with a 
BMI ≥ 30 had a higher risk of 
miscarriage compared to women with a 
BMI < 30 (OR 1.53, 95% CI 1.27-1.84 (p 
<0.001)15. The current literature 
indicates that, regardless of the method 
of conception, miscarriage risk is related 
to obesity rather than PCOS or any 
other cause of infertility. 
 
Higher multiple pregnancy rate, parity 
and BMI in women with PCOS were 
important risks contributing to the 
development of GDM10. Our study 
showed that BMI was an independent 
risk factor for the development of GDM 
after controlling for age and PCOS 
diagnosis. The independent risk of GDM 
in women with PCOS has been 
investigated in several populations but 
remains controversial. In a Finnish study 
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99 women with PCOS (ultrasound 
appearance of polycystic ovaries and 
hyperandrogenism, with or without 
irregular menses) were compared to 
737 geographically matched controls16. 
The risk of developing GDM was largely 
explained by obesity and the 
independent association with PCOS 
could not be demonstrated in singleton 
pregnancies. In a Czech study including 
PCOS women (n=66) and age and 
weight matched controls (n=66) no 
difference was detected in the risk of 
GDM17. A recent population-based U.S. 
study reported a higher prevalence of 
GDM among women with PCOS 
(n=1,542) compared to controls (OR 2.4, 
95% CI: 2.1-2.83)18.  However, despite 
its large sample size, a major drawback 
of this study was that BMI was not 
included in the analysis. A recent meta-
analysis of five studies demonstrated a 
higher risk of developing GDM in women 
with PCOS (OR 3.66, 95% CI: 1.20–
11.16) however, significant statistical 
heterogeneity was present in these 
studies10.The risk of developing GDM in 
all women is reported to be about two, 
four, and eight times higher based on 
overweight, obese, and severely obesity 
respectively, compared with normal-
weight19. Larger studies are therefore 
needed in a well characterized PCOS 
population to determine the independent 
risk of GDM. 
 
Our study suggests a possible 
association between PCOS and PIH but 
was limited by sample size.  As 
expected preexisting hypertension and 
nulliparity was associated with 
increased risk of preeclampsia. The 
prevalence of preeclampsia appears to 
be two-fold greater in women with 
PCOS, but was not statistically 
significant in our study.  In a recent 
study of women with PCOS a subgroup 
analysis of only two higher validity 
studies was performed and reported a 
significantly increased risk of PIH (OR 
3.71, 95% CI: 1.72–17.49)10. In the 
same study women with PCOS also 
demonstrated a significantly higher 
chance of developing preeclampsia (OR 
3.47, 95% CI: 1.95–6.17). However, no 
subgroup analysis could be performed 
as variables such as parity, BMI and 
multiple pregnancy differed in the 
studies included.  As reported in 
previous studies we did not find an 
increased risk of PTD delivery 
independent of multiple gestations in 
women with PCOS10. Similarly we did 
not find an increased risk of macrosomia 
or SGA in children born to women with 
PCOS. Studies have demonstrated an 
increased risk of poor obstetric 
outcomes (preterm delivery, low birth 
weight) in singleton pregnancies 
resulting from IVF20,21. Both groups in 
our study conceived after IVF thereby 
controlling for any confounding effect. 
 
In summary our study demonstrates that 
the miscarriage rate in women with 
PCOS after IVF is not increased 
independent of BMI. However, BMI 
alone was significantly associated with 
increased risk of gestational diabetes. 
Preexisting hypertension in the PCOS 
population was associated with an 
increased risk of preeclampsia. These 
findings underscore the need for 
clinicians to diligently screen women 
with PCOS for the presence of obesity 
and hypertension. Physicians have an 
opportunity to screen women prior to 
assisting conception and offer nutritional 
counseling and weight loss strategies. 
Obese women with PCOS should be 
monitored closely in pregnancy for the 
development of GDM, PIH and 
preeclampsia.  Accurate identification of 
these morbidities in pregnancy is critical 
as the affected group of women may 
also be at increased risk for 
hypertension, heart disease and 
cardiovascular events later in life22, 23. 
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Future studies should aim to examine 
the effects of interventions such as 
prepregnancy weight loss on 
miscarriage rate and risk of GDM in 
women with PCOS. 
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